AML Electronic Decision Aid

Duke University20 enrolled

Overview

The purpose of this study is to test the feasibility and preliminary efficacy of a novel electronic decision aid to improve AML patients' understanding of their illness, prognosis, and treatment options. The objective of our program of research is to ultimately improve understanding about what patients with Acute Myeloid Leukemia (AML) know and understand about their disease, as well as what kind of information AML patients want or need to further inform them about the treatment decisions they face. The AML Decision Aid tool consists of ten video modules, approximately 3 minutes each, containing content regarding key areas such as an explanation of what AML is, treatment choices, and things to consider when determining a treatment path. Recruited subjects will complete a series of surveys, both before viewing of the videos and after

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Acute Myeloid Leukemia

Interventions

Electronic Decision Aid ToolOTHER

The AML Decision Aid tool consists of ten video modules, approximately 3 minutes each, containing content regarding key areas such as an explanation of what AML is, treatment choices, and things to consider when determining a treatment path.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * At least age 18 * Capacity to give consent * Diagnosis of acute myeloid leukemia (AML) * Fluent in English * Receiving care at Duke, and fits into one of the following scenarios: * has not yet made a treatment decision (in the DCI clinics or on the inpatient wards), * have recently made a decision (in the last 6 weeks), and are admitted for chemotherapy on 9100 or in the oncology treatment center to receive outpatient therapy, * or, during remission, while receiving consolidation chemotherapy in the hospital Exclusion Criteria: * Patients too sick to participate per clinician discretion

Locations (1)

Duke University Medical Center

Durham, North Carolina, United States

Outcomes

Primary Outcomes

Number of enrolled subjects who have completed the study

Feasibility will be determined by enrolled subjects who complete the study (including watching all videos, and completing the surveys).

Time frame: 1 day

Secondary Outcomes

Change in knowledge about AML after video viewing

Efficacy will be measured by change in knowledge about AML, (including knowledge about the disease itself, and comprehending AML treatment choices and their risks, as measured through changes in AML Knowledge Questionnaire scores)

Time frame: Day 1. Pre-video screening and post-video

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.